about
Angiomyogenesis for myocardial repair.Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expressionSpliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarctionFocal adhesion kinase regulation of neovascularization.Human pericytes for ischemic heart repairMyocardial repair: from salvage to tissue reconstruction.Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.Update on therapeutic vascularization strategies.Dual gene transfer of bFGF and PDGF in a single plasmid for the treatment of myocardial infarction.Therapeutic potential of Rb phosphorylation in atherosclerosis.Blood supply of the graft after cellular cardiomyoplasty.Re-engineered stromal cell-derived factor-1α and the future of translatable angiogenic polypeptide design.Advances in growth factor delivery for therapeutic angiogenesis.The Role of Synthetic Extracellular Matrices in Endothelial Progenitor Cell Homing for Treatment of Vascular Disease.Baicalin increases VEGF expression and angiogenesis by activating the ERR{alpha}/PGC-1{alpha} pathway.The neovascularization effect of bone marrow stromal cells in temporal muscle after encephalomyosynangiosis in chronic cerebral ischemic rats.Role of a Burr Hole and Calvarial Bone Marrow-Derived Stem Cells in the Ischemic Rat Brain: A Possible Mechanism for the Efficacy of Multiple Burr Hole Surgery in Moyamoya Disease.Angiogenic potential of microvessel fragments is independent of the tissue of origin and can be influenced by the cellular composition of the implants.Insulin-Like Growth Factor-1 (IGF-1) Reduces ischemic changes and increases circulating angiogenic factors in experimentally - induced myocardial infarction in rats.How Can We Cheat Arterial Atherosclerosis?An inconvenient truth: recognizing individual differences in arteriogenesisJaceosidin, a natural flavone, promotes angiogenesis via activation of VEGFR2/FAK/PI3K/AKT/NF-κB signaling pathways in endothelial cells.Long-Term and Sustained Therapeutic Results of a Specific Promonocyte Cell Formulation in Refractory Angina: ReACT(®) (Refractory Angina Cell Therapy) Clinical Update and Cost-Effective Analysis.Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
P2860
Q30480151-C63132C8-1663-435D-8663-AC3D811CC71EQ33999277-0D68A95C-237E-41C8-BFF9-6ACFB0494CF8Q34056983-08EE3C3E-654C-4BEA-914B-DA462A4DC58AQ35269444-6D52CE83-AD6B-4519-BB0B-7CF682483421Q36609495-070D61C0-0190-4B9F-959C-58D3E93ED999Q37176440-5CB06464-F1F4-4357-80D6-F9770A13D183Q37228936-C3FA16D2-30EC-445E-B436-76C120D20793Q37357266-6C76B414-C50C-404B-8D96-6A7B049B0B76Q37574875-93E3081D-A219-44CE-B625-45F6A6D22D0DQ37641519-0E71968B-D9D4-42B2-8653-CA681DBF65A1Q37792119-24389F31-5BEB-4E61-8DBD-525C01557A48Q38035620-8B84B9D9-3D3E-4BA7-B56B-51B31EBE0A34Q38060077-B957A8D6-8901-40ED-AB27-F40B2FD61C59Q38553350-A0171015-571A-434B-8582-B9AC3354039AQ39654160-0ACCC858-11F1-4F8C-9E5E-FC17C03CA4C4Q41605851-D6D21F4D-E827-44BC-A1DB-4C1D532D2A08Q41876726-72BC85CD-4635-4964-90F0-A367D15A03E8Q42080478-9794FFD3-BDAF-48C1-B4A4-1AE4C521C127Q42087231-9511A57F-712F-4E61-AF1D-D65AC25D78DBQ42362180-3B404972-A84A-4695-939B-DA4C56C76AB6Q42587047-3EAEFDE3-38F5-4211-8B42-E015AC17A92AQ46878072-6D376DD0-D1E6-4DA2-9945-356887F391ACQ48076745-06E24139-66EE-4F71-B166-539DAC4027CAQ53068300-F589D050-9885-4AF6-9BB6-8B9FEA1B59F8
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Therapeutic myocardial angiogenesis
@en
type
label
Therapeutic myocardial angiogenesis
@en
prefLabel
Therapeutic myocardial angiogenesis
@en
P2860
P1476
Therapeutic myocardial angiogenesis
@en
P2093
Douglas W Losordo
Marie-Ange Renault
P2860
P304
P356
10.1016/J.MVR.2007.08.005
P577
2007-09-07T00:00:00Z